Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q3 CY2025 results , with sales up 11.9% year on year ...

The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...

MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...

A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...

Liquid biopsies analyze materials like circulating tumor DNA (ctDNA) in the blood to provide a non-invasive look at a cancer’s genetic profile. They are highly effective for tracking tumor evolution, ...

The Seestar S30 is introduced as a compact, all-in-one astroimaging system by ZWO, designed for capturing deep-sky objects through integrated optics, automated tracking, and a user-friendly software ...

SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...

Marathon, Bungie's upcoming sci-fi extraction shooter, has reared its head again, as the studio has announced a closed technical test to run later this month. Given the fact that it's a closed ...